Work Here?
About B Capital Group
Industries
Venture Capital
Fintech
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
$15.3B
Headquarters
New York City, New York
Founded
2015
Overview
B Capital Group is a global investment firm that focuses on providing capital and support to entrepreneurs in the Technology, Healthcare, and Climate sectors. The firm manages over $6 billion in assets and invests in companies at various stages, from seed to late-stage growth. B Capital's approach includes leveraging a team spread across nine locations in the US and Asia, which allows them to offer strategic guidance and help businesses scale effectively. A key aspect that sets B Capital apart from its competitors is its partnership with BCG, which enhances their ability to assist companies in entering new markets and developing strong business models. The goal of B Capital is to partner with exceptional entrepreneurs to shape the future through technology.
Simplify's Take
What believers are saying
- Increased interest in AI healthcare solutions boosts B Capital's investment potential.
- Humanoid robotics trend offers new opportunities for B Capital's portfolio companies.
- AI-driven supply chain solutions in life sciences present lucrative investment opportunities.
What critics are saying
- High competition in AI sector may divert investment from B Capital's companies.
- Rapid expansion of portfolio companies could lead to operational challenges.
- Focus on high-risk sectors like brain-computer interfaces exposes B Capital to financial risks.
What makes B Capital Group unique
- B Capital Group partners with BCG for strategic support and market expansion.
- The firm has a multinational presence with offices in the US and Asia.
- B Capital focuses on technology, healthcare, and climate sectors for diversified investments.
Help us improve and share your feedback! Did you find this helpful?
Funding
Total Funding
$15283.3M
Above
Industry Average
Funded Over
0 Rounds
Benefits
Hybrid Work Options
Company News
B Capital, Capital Factory and Google back Apptronik in the race to develop and deploy humanoid robots at scale
Mistral AI, France’s open-source answer to OpenAI, plans to go public instead of being acquired. “We are not for sale,” CEO and co-founder Arthur Mensch told Bloomberg TV Tuesday (Jan. 21). There had been speculation that the startup would be acquired by Microsoft, in part due to a partnership and the tech giant’s investment of 15 million euros ($15.6 million) in Mistral. (Microsoft has invested nearly $14 billion in OpenAI.)
Labviva, an AI procurement platform for life sciences, secured $25 million in Series B funding, totaling $55 million. Led by 53 Stations, with participation from Biospring Partners, B Capital Group, and Glasswing Ventures, the funds will accelerate product development, marketing, and global expansion. Jason Pritzker from 53 Stations joins Labviva's Board. Labviva aims to enhance supply chain transparency and efficiency in life sciences, supporting major pharmaceutical companies and research institutions.
Innovaccer has raised a $275M Series F from investors including B Capital Group, Banner Health, Danaher Ventures, Generation IM, Kaiser Permanente, and M12.
Series C Funding Round Establishes Precision as the Best-Funded Brain–Computer Interface Company After Neuralink...
B Capital Group is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today
About B Capital Group
Industries
Venture Capital
Fintech
Healthcare
Company Size
51-200
Company Stage
N/A
Total Funding
$15.3B
Headquarters
New York City, New York
Founded
2015
B Capital Group is Hiring for 0 Jobs on Simplify!
Find jobs on Simplify and start your career today